Revenue
2018
2019
2020
2021
2022
2023
2024
2025
GUIDED THERAPEUTICS INC (GTHP)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2016
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $767,000 | $7,000 | $98,000 | $13,000 | $81,000 | $102,000 | $36,000 | $57,000 | $244,000 | $0 | $42,000 | $65,000 | $820,000 | $3.3M | $3.6M | $3.4M |
| Gross profit | $571,000 | $2,000 | $36,000 | −$68,000 | $20,000 | $143,000 | −$34,000 | −$32,000 | −$286,000 | $112,000 | $27,000 | −$133,000 | −$252,000 | −$45,000 | −$81,000 | — |
| Research & development | $469,000 | $526,000 | $228,000 | $77,000 | $69,000 | $143,000 | $122,000 | $244,000 | $334,000 | $733,000 | $1.5M | $2.8M | $2.7M | $3.2M | $2.8M | $1.8M |
| Operating expenses | $2.9M | $2.1M | $3.5M | $3.3M | $2.4M | $1.2M | $903,000 | $1.5M | $2.8M | $3.9M | $6.3M | $8.6M | $7.2M | $7.6M | $10.3M | — |
| Operating income | −$2.4M | −$2.1M | −$3.5M | −$3.3M | −$2.4M | −$1.1M | −$937,000 | −$1.5M | −$3.1M | −$3.8M | −$6.2M | −$8.7M | −$6.6M | −$4.3M | −$6.8M | −$1.6M |
| EBITDAderived | — | — | — | — | — | −$1.1M | −$916,000 | −$1.5M | −$2.9M | −$2.6M | −$5.2M | −$7.4M | −$6.1M | −$3.9M | −$6.7M | — |
| Net income | −$3.2M | −$2.4M | −$3.5M | −$4.3M | −$2.1M | −$279,000 | −$1.9M | $1.0M | −$10.7M | −$4.0M | −$6.9M | −$9.9M | −$7.2M | −$4.4M | −$6.6M | −$2.8M |
| Basic EPSper diluted share | -$0.04 | -$0.05 | -$0.07 | -$0.15 | -$0.18 | -$0.04 | -$0.58 | $1.95 | $997.64 | -$24.62 | -$5,939.38 | -$13.02 | -$0.16 | -$0.08 | -$0.14 | -$0.12 |
| Diluted EPSper diluted share | -$0.04 | -$0.05 | -$0.07 | -$0.15 | -$0.18 | -$0.04 | -$0.58 | $0.01 | $0.00 | -$24.62 | -$5,939.38 | -$13.02 | -$0.16 | -$0.08 | -$0.14 | -$0.12 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Aug 29, 2025Form 4 | Grujic AlanDirector | BuyCommon Stock | 152.1K | — | — | 1.82M |
| Aug 29, 2025Form 4 | Grujic AlanDirector | BuyWarrants · derivative | 152.1K | — | — | 177.1K |
| Aug 29, 2025Form 4 | Imhoff John EDirector,TenPercentOwner | BuyCommon Stock | 166.7K | $0.18 | $30.0K | 19.46M |
| Aug 29, 2025Form 4 | Imhoff John EDirector,TenPercentOwner | BuyWarrants · derivative | 166.7K | — | — | 191.7K |
| Aug 29, 2025Form 4 | JAMES MICHAEL CDirector | BuyCommon Stock | 27.8K | $0.18 | $5.0K | 553.5K |